过去一年中添加的文章,按日期排序

Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real‐world …

H Shin, SU Kim, BG Song, Y Park, Y Ko… - Hepatology …, 2024 - Wiley Online Library
106 天前 - … the impact of TAF use after curative treatment on HCC … Among 2794 consecutive
patients with chronic hepatitis Bpropensity score matching. Time-dependent Cox regression …